Fluorescent (rhodamine), folate decorated and doxorubicin charged, PEGylated nanoparticles synthesis

Journal of Materials Science: Materials in Medicine

Volumn 23, Issue 7, 2012, Pages 1697-1704

  Silvestri, B ^a   Guarnieri, D ^b   Luciani, G ^a   Costantini, A ^a   Netti, P A ^a,b   Branda, F ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AQUEOUS SOLS; CARBODIIMIDE HYDROCHLORIDES; DOXORUBICIN; ENCAPSULATION EFFICIENCY; FOLIC ACIDS; FUNCTIONALIZATIONS; PEGYLATED NANOPARTICLE; SILICA NANOPARTICLES; SYNTHESIS ROUTE; THERAPEUTIC EFFICACY;

ENCAPSULATION; ORGANIC ACIDS;

SYNTHESIS (CHEMICAL);

1 (3 DIMETHYLAMINOPROPYL) 3 ETHYLCARBODIIMIDE; DOXORUBICIN; FOLIC ACID; ISOTHIOCYANIC ACID; NANOPARTICLE; RHODAMINE; RHODAMINE B;

ARTICLE; HUMAN; HUMAN CELL; NANOENCAPSULATION; PRIORITY JOURNAL; SYNTHESIS;

DOXORUBICIN; FEMALE; FLUORESCENT DYES; FOLIC ACID; HUMANS; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; POLYETHYLENE GLYCOLS; RHODAMINES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84863321917     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-012-4634-2     Document Type: Article

References (49)

1. Vivero Escoto JL, Slowing II, Trewyn BG, Lin VSY. Mesoporous silica nanoparticles for intracellular controlled drug delivery. Small. 2010;6:1952-67.
2. Mishra B, Patel BB, Tiwari S. Colloidal nanocarriers: a review on formulation technology types and applications toward targeted drug delivery. Nanomedicine. 2010;6:9-24.
3. Davis ME, Chen Z, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov. 2008;7:771-82.
4. Will O, Purkayastha S, Chan C, Athanasiou T, Darzi AW, Gedroy W, et al. Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis. Lancet Oncol. 2005;7:52-60.
5. Weissleder R. Molecular imaging in cancer. Science. 2006;312: 1168-71. (Pubitemid 43801133)
6. Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med. 2006;12:895-904. (Pubitemid 44175140)
7. Huang HC, Barua S, Sharma G, Dey SK, Rege K. Inorganic nanoparticles for cancer imaging and therapy. J Control Release. 2011;155:344-57.
8. Hoshino A, Fujioka K, Oku T, Nakamura S, Suga M, Yamaguchi Y, et al. Quantum dots targeted to the assigned organelle in living cells. Microbiol Immunol. 2004;48:985-94. (Pubitemid 40040708)
9. Jaiswal J, Goldman E, Mattoussi H, Simon S. Use of quantum dots for live cell imaging. Nat Methods. 2004;1:73-8.
10. Michalet X, Pinaud F, Bentolila L, Tsay J, Doose S, Li J, et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science. 2005;307:538-44. (Pubitemid 40165671)
11. Chen F, Gerion D. Fluorescent CdSe/ZnS nanocrystalepeptide conjugates for long-term, nontoxic imaging and nuclear targeting in living cells. Nano Lett. 2004;4:1827-32.
12. Jason E, Fuller A, Gregory T, Zugates A, Lino S, et al. Langer Intracellular delivery of coreshell fluorescent silica nanoparticles. Biomaterials. 2008;29:1526-32.
13. Derfus AM, Chan WCW, Bhatia SN. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett. 2004;4:11-8. (Pubitemid 38167855)
14. Seydel C. Quantum dots get wet. Science. 2003;300:80-1. (Pubitemid 36423030)
15. Colvin VL. The potential environmental impact of engineered nanomaterials. Nat Biotechnol. 2003;21:1166-70. (Pubitemid 37203347)
16. Stöber W, Fink A. Controlled growth of monodisperse silica spheres in the micron size range. J Colloid Interf Sci. 1968;26: 62-9.
17. Brinker CJ, Sherer W. Sol-Gel science: the physics and chemistry of sol-gel processing. San Diego: Academic Press; 1990.
18. Yagüe C, Moros M, Grazù V, Arruebo M, Santamarìa J. Synthesis and stealthing study of bare and PEGylated silica microand nanoparticles as potential drug delivery vectors. Chem Eng J. 2008;137:42-53.
19. Livage J, Coradin T, Roux C. Encapsulation of biomolecules in silica gels. J Phys-Condens Mat. 2001;13:673-91.
20. Radin S, El-Bassyouni G, Vresilovic EJ, Schepers E, Ducheyne P. In vivo tissue response to resorbable silica xerogels as controlled release materials. Biomaterials. 2000;21:193-8.
21. Kortesuo P, Ahola M, Karlsson S, Kangasniemi I, Yli-Urpo A, Kiesvaara J. Silica xerogel as an implantable carrier for controlled drug delivery evaluation of drug distribution and tissue effects after implantation. Biomaterials. 2000;21:193-8.
22. Radin S, Falaize S, Lee MH, Ducheyne P. In vitro bioactivity and degradation behaviour of silica xerogels intended as controlled release materials. Biomaterials. 2002;23:3113-22. (Pubitemid 34522124)
23. Costantini A, Luciani G, Annunziata G, Silvestri B, Branda F. Swelling properties and bioactivity of silica gel/pHEMA nanocomposites. J Mater Sci Mater Med. 2006;17:319-25.
24. Costantini A, Luciani G, Silvestri B, Tescione F, Branda F. Bioactive poly(2-hydroxyethylmethacrylate)/silica gel hybrid nanocomposites prepared by sol-gel process. J Biomed Mater Res B Appl Biomater. 2008;86B(1):98-104. (Pubitemid 351874372)
25. Branda F, Silvestri B, Luciani G, Costantini A. The effect of mixing alkoxides on the Stöber particles size. Colloids Surf A: Physicochem Eng Aspects. 2007;299:252-5. (Pubitemid 46454371)
26. Bogush GH, Tracy MA, Zukosky CF. Preparation of monodisperse silica particles: control of size and mass fraction. J Non-Cryst Solids. 1988;104:95-106. (Pubitemid 18660677)
27. Verne E, Vitale-Brovarone C, Bui E, Bianchi CL, Boccaccini AR. Surface functionalization of bioactive glasses. J Biomed Mater Res A. 2009;90:981-92.
28. Kessler D, Roth PJ, Theato P. Reactive surface coatings based on polysilsesquioxanes: controlled functionalization for specific protein immobilization. Langmuir. 2009;25:10068-76.
29. 2 hybrids derived through in situ sol-gel process. J Sol-Gel Sci Technol. 2008;46(2):166-75.
30. Branda F, Silvestri B, Luciani G, Costantini A, Tescione F. Synthesis structure and stability of amino functionalized PEGylated silica nanoparticles. Colloids Surf A: Physicochem Eng Aspects. 2010;367:12-6.
31. Alcantar NA, Aydil ES, Israelachvili JN. Polyethylene glycolcoated biocompatible surfaces. J Biomed Mater Res. 2000;51: 343-51.
32. Nagaoka S, Nakao A. Clinical application for antithrombogenic hydrogel with long poly(ethylene oxide) chains. Biomater. 1990; 11:119-21. (Pubitemid 20119321)
33. Harris M. Poly(ethylene glycol) chemistry: biotechnical and biomedical applications. New York: Plenum Press; 1992.
34. Kingshott P, Griessar HJ. Surfaces that resist bioadhesion. Curr Opin Solid St M. 1999;4:403-12. (Pubitemid 129500392)
35. Shan X, Yuan Y, Liu C, Tao X, Sheng Y, Xu F. Influence of PEG chain on the complement activation suppression and longevity in vivo prolongation of the PCL biomedical nanoparticles. Biomed Microdevices. 2009;11:1187-94.
36. Van Blaaderen A, Vrij A. Synthesis and characterization of colloidal dispersions of fluorescent, monodisperse silica spheres. Langmuir. 1992;8:2921-31. (Pubitemid 23613916)
37. Zhang J, Rana S, Srivastava RS, Misra RDK. On the chemical synthesis and drug delivery response of folate receptor-activated, polyethylene glycol-functionalized magnetite nanoparticles. Acta Biomater. 2008;4:40-8. (Pubitemid 350131553)
38. Moghimi SM, Rajabi-Siahboomi AR. Recent advances in cellular, sub-cellular and molecular targeting. Adv Drug Deliv Rev. 2000;41:129-33. (Pubitemid 30122953)
39. Hood JD, Bednarski M, Frausto R, Guccione S, Reisfeld RA, Xiang R, et al. Tumor regression by targeted gene delivery to the neovasculature. Science. 2002;296:2404-7. (Pubitemid 34734217)
40. Weissleder R, Cheng HC, Bogdanova A, Bogdanov A. Magnetically labeled cells can be detected by MR imaging. J Magn Reson Imaging. 1997;7:258-63. (Pubitemid 28365670)
41. Weitman SD, Lark RH, Coney LR, Fort DW, Frasca V, Zurawski VR, et al. Distribution of the folate receptor Gp38 in normal and malignant-cell lines and tissues. Cancer Res. 1992;52:3396-401.
42. Deshpande AV, Namdas EB. Correlation between lasing and photophysical performance of dyes in polymethylmethacrylate. J Lumin. 2000;9:125-31.
43. Park J, Fong PM, Lu J, Russell KS, Booth CJ, Saltzman WM, Fahmy TM. PEGylated PLGA nanoparticles for the improved delivery of doxorubicin. Nanomedicine. 2009;5:410-8.
44. Saravanan L, Subramanian S. Surface chemical studies on the competitive adsorption of poly(ethylene glycol) and ammonium poly(methacrylate) onto alumina. J Colloid Interf Sci. 2005; 284:363-77. (Pubitemid 40385894)
45. Xu H, Yan F, Monson EE, Kopelman R. Room-temperature preparation and characterization of poly(ethylene glycol)-coated silica nanoparticles for biomedical applications. J Biomed Mat Res Part A. 2003;66:870-9. (Pubitemid 37521413)
46. Santra S, Zhang P, Wang K, Tapec R, Tan W. Conjugation of biomolecules with luminophore-doped silica nanoparticles for photostable biomarkers. Anal Chem. 2001;73:4988-93. (Pubitemid 32980123)
47. Lu Y, Low PS. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv Drug Deliv Rev. 2002;54: 675-93. (Pubitemid 35247522)
48. Choi H, Choi SR, Zhou R, Kung HF, Chen IW. Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery. Acad Radiol. 2004;11:996-1004. (Pubitemid 39220809)
49. Bénard J, Da Silva J, De Blois MC, Boyer P, Duvillard P, Chiric E, Riou G. Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice. Cancer Res. 1985;45:4970-9. (Pubitemid 16236181)